Also, Dallavalle et al. reported that a POLA1-HDAC1 dual inhibitor, MIR002, inhibits the primer extension activity of POLA1, resulting in antiproliferative effects on various human cancer cell lines, including ovarian cancer66. This evidence concerns the gene HDAC1 and cancer.